PHARMA SERVICES M&A
M&A advisory services for
pharma services business owners
WHY ECLIPSE?
-
The Eclipse team supports pharma services business owners in realising the value they have built through successful company sales or by taking on private equity investment
-
We have completed transactions across the healthcare sector including pharma services, clinical services, specialist care, medico-legal and children's services
-
This has helped numerous founders reap the rewards of their hard work through successful exits, providing them with the financial freedom to retire, "de-risk" or plan for whatever comes next
-
We are not a high volume firm - this allows us to spend more time producing higher quality, tailored marketing materials and provide a greater level of support throughout the sale process
-
Our experience advising on varied and complex deals of up to £100m gives us significant expertise in running smooth and efficient processes, ensuring that value is protected through to completion of the transaction
-
Our fees are transparent and directly linked to the valuation achieved
OVERVIEW
The UK pharma services sector continues to see strong M&A activity, driven by a combination of corporate acquirers and private equity investors.
Our core areas of focus in the sector are as follows:
-
CROs
-
CDMOs
-
Medical Communications
-
Regulatory Affairs and Market Access
-
Generic Pharmaceuticals
-
Speciality Pharmaceuticals
If you are considering selling your pharma services business or are considering taking on private equity investment, the Eclipse team can support you in maximising value whilst delivering a smooth and efficient process.
As chartered accountants with significant investment banking experience, we differentiate ourselves from other advisors by taking a hands on, end-to-end approach to ensure the optimum outcome for our clients.
Our latest insights into M&A in the pharma services sector can be found below.
INSIGHTS
